Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lamotrigine overdose in a child.

Muhannad Daana1, Yoram Nevo, Ariel Tenenbaum

  • 1Department of Pediatrics, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Journal of Child Neurology
|August 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-draining lymph nodes in ovarian cancer lack germinal centers but harbor tumor-reactive memory B cells clonally linked to intra-tumoral B cells.

Immunity·2026
Same author

Islet autoantibody profiles at diagnosis of childhood type 1 Diabetes: Age-Dependent heterogeneity and clinical implications.

Diabetes research and clinical practice·2026
Same author

Patient-derived brain organoids reveal divergent neuronal activity across subpopulations of autism spectrum disorder.

Translational psychiatry·2026
Same author

Vaccination decision-making in children with intellectual and developmental disabilities- it's a matter of trust.

Vaccine·2026
Same author

The effects of transcranial random noise stimulation on excitation/inhibition balance in ADHD.

NeuroImage. Clinical·2026
Same author

Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children.

Steroids·2025
Same journal

Genetic Etiologies and Risk Factors for Regressive Autism and Childhood Disintegrative Disorder: A Scoping Review.

Journal of child neurology·2026
Same journal

Birmingham, 1963.

Journal of child neurology·2026
Same journal

Hyperintensity on Diffusion-Weighted Imaging in a MELAS Patient Does Not Necessarily Mean Cytotoxic Edema.

Journal of child neurology·2026
Same journal

Neuromuscular Symptoms of <i>ORAI1</i>-Related Immunodeficiency.

Journal of child neurology·2026
Same journal

Symptoms of Obsessive-Compulsive Disorder, Attention-Deficit/Hyperactivity Disorder, and Autism Spectrum Disorder in Children and Adolescents Attending a Headache Outpatient Clinic and School-Based Controls.

Journal of child neurology·2026
Same journal

Acute Encephalopathy From Central Nervous System Hemophagocytic Lymphohistiocytosis (CNS HLH) in X-Linked Lymphoproliferative Disease Type 1 (XLP-1).

Journal of child neurology·2026
See all related articles

A young child experienced lamotrigine toxicity at a lower dose than previously documented, highlighting a narrow safety margin for pediatric epilepsy treatment. This case underscores the need for careful monitoring of lamotrigine dosage in children.

Area of Science:

  • Pediatric Neurology
  • Clinical Toxicology

Background:

  • Lamotrigine is a widely used antiepileptic drug.
  • Previous reports indicated a minimum toxic dose of 800 mg in children.

Observation:

  • A 5-year-old girl on lamotrigine monotherapy presented with ataxia, drowsiness, and confusion.
  • Symptoms occurred after ingesting 500 mg (25 mg/kg/d), with toxicity noted after the initial 250 mg dose.

Findings:

  • This case demonstrates lamotrigine toxicity at a significantly lower dose (250 mg) than previously reported.
  • The patient experienced ataxia, drowsiness, confusion, vomiting, and seizure exacerbation.

Implications:

  • This case highlights a potentially narrow safety margin for lamotrigine in pediatric patients.

Related Experiment Videos

  • Clinicians should exercise caution and consider close monitoring even at lower lamotrigine dosages in children.
  • Further research may be warranted to establish precise pediatric dosing guidelines and toxicity thresholds.